Literature DB >> 20682500

Perceptions and experiences of patients receiving oral chemotherapy.

Brett Simchowitz1, Lawrence Shiman, Justin Spencer, Daniela Brouillard, Anne Gross, Maureen Connor, Saul N Weingart.   

Abstract

Although many patients prefer orally administered cancer therapy (including oral chemotherapy) because of its convenience, the shift from hospital to home-based administration creates concerns. This article explores the perceptions and experiences of oral chemotherapy users and their caregivers to assess vulnerabilities and improvement opportunities at each stage of the medication process: choosing oral chemotherapy, prescribing, dispensing, administering, and monitoring. The authors recruited 15 current and former oral chemotherapy users, as well as caregivers who administered the medications to children, to participate in one of two focus group sessions at a comprehensive cancer center. Participants largely were satisfied with oral cancer therapy but raised concerns regarding their lack of preparedness for side effects and their unfamiliarity with the possible techniques to mitigate drug toxicity. Participants also described difficulties obtaining medications through retail pharmacies. Parents of pediatric patients with cancer indicated concerns regarding their children's emotional health and correct medication administration. Participants believed that the initial prescribing encounter should have included more education, and they also wanted more frequent follow-up by healthcare practitioners. As oral cancer therapy is used more widely, oncology healthcare providers will need to create robust mechanisms to support their safe use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682500     DOI: 10.1188/10.CJON.447-453

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  7 in total

1.  Survey of oral chemotherapy safety and adherence practices of hospitals in Spain.

Authors:  David Conde-Estévez; Esther Salas; Joan Albanell
Journal:  Int J Clin Pharm       Date:  2013-10-16

2.  US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards.

Authors:  Saul N Weingart; Justin W Li; Junya Zhu; Laurinda Morway; Sherri O Stuver; Lawrence N Shulman; Michael J Hassett
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840

Review 3.  Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review.

Authors:  Marco Di Nitto; Fabio Sollazzo; Valentina Biagioli; Gianluca Pucciarelli; Francesco Torino; Rosaria Alvaro; Ercole Vellone
Journal:  Support Care Cancer       Date:  2022-05-31       Impact factor: 3.359

Review 4.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

5.  Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.

Authors:  Lisa Hammond; Elaine Marsden; Niamh O'Hanlon; Fionnuala King; Martin Charles Henman; Claire Keane
Journal:  Int J Clin Pharm       Date:  2012-09-09

6.  Over compliance with capecitabine oral chemotherapy.

Authors:  Jennifer Allen; Steve Williamson
Journal:  Int J Clin Pharm       Date:  2014-02-15

7.  Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross-sectional study.

Authors:  Ningsheng Wang; Biqi Ren; Haisheng You; Yue Chen; Shuzhi Lin; Shuang Lei; Bianling Feng
Journal:  Health Expect       Date:  2022-01-05       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.